Expression of keratinocyte growth factor and its receptor in noncholesteatomatous and cholesteatomatous chronic otitis media

Otology and Neurotology

Volumn 31, Issue 5, 2010, Pages 745-751

  Yamamoto Fukuda, Tomomi ^a   Takahashi, Haruo ^a   Terakado, Mariko ^a   Hishikawa, Yoshitaka ^a   Koji, Takehiko ^a  

^a NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cholesteatoma; Immunohistochemistry; Keratinocyte growth factor; KGF receptor; Ki 67; Noncholesteatomatous chronic otitis media

Indexed keywords

CD20 ANTIGEN; CD45 ANTIGEN; FIBROBLAST GROWTH FACTOR RECEPTOR 2; KERATINOCYTE GROWTH FACTOR; KERATINOCYTE GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; BIOSYNTHESIS; CELL COUNT; CELL PROLIFERATION; CHILD; CHOLESTEATOMA; CHRONIC DISEASE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; INFANT; MALE; METABOLISM; MIDDLE AGED; OTITIS MEDIA; PHYSIOLOGY; PRESCHOOL CHILD; T LYMPHOCYTE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD20; ANTIGENS, CD45; B-LYMPHOCYTES; CELL COUNT; CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; CHOLESTEATOMA, MIDDLE EAR; CHRONIC DISEASE; FEMALE; FIBROBLAST GROWTH FACTOR 7; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KI-67 ANTIGEN; MALE; MIDDLE AGED; OTITIS MEDIA; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; T-LYMPHOCYTES; YOUNG ADULT;

EID: 77954387414     PISSN: 15317129     EISSN: 15374505     Source Type: Journal    
DOI: 10.1097/MAO.0b013e3181dd15ef     Document Type: Article

References (25)

1. Harker LA. Cholesteatoma an evidence study. In: McCabe BF, Sade J, Abramson M, eds. Cholesteatoma First International Conference. Birmingham, AL: Aesculapius, 1997:308-9.
2. Tos M. Incidence, etiology and pathogenesis of cholesteatoma in children. Adv Otorhinolaryngol 1988;40:110-7.
3. Osma U, Cureoglu S, Hosoglu S. The complication of chronic otitis media: report of 93 cases. J Laryngol Otol 2000;114: 97-100.
4. Kim HJ, Tinling SP, Chole RA. Expression patterns of cytokeratins in retraction pocket cholesteatomas. Laryngoscope 2001;111: 1032-6.
5. Sculerati N, Bluestone CD. Pathogenesis of cholesteatoma. Otolaryngol Clin North Am 1989;22:859-68.
6. Sudhoff H, Bujia J, Fisseler-Eckhoff A, et al. Expression of a cell-cycleYassociated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin. Laryngoscope 1995;105:1227-31.
7. Kojima H, Shiwa M, Kamide Y, et al. Expression and localization of mRNA for epidermal growth factor and epidermal growth factor receptor in human cholesteatoma. Acta Otolaryngol 1994;114: 423-9.
8. Schulz P, Bujia J, Holly A, et al. Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha. Am J Otolaryngol 1993;14:82-7.
9. Schilling V, Negri B, Bujia J, et al. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Am J Otol 1992;13:350-5.
10. Wright CW, Meyerhoff WM. Pathology of otitis media. Ann Otol Rhinol Laryngol 1994;103:24-6.
11. Yamamoto-Fukuda T, Aoki D, Hishikawa Y, et al. Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma. Lab Invest 2003;83:123-36.
12. Yamamoto-fukuda T, Terakado M, Hishikawa Y, et al. Topical application of 5-fluorouracil on attic cholesteatoma results in downregulation of keratinocyte growth factor and reduction of proliferative activity. Eur Arch Otorhinolaryngol 2008;265: 1173-8.
13. Finch PW, Rubin JS, Miki T, et al. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 1989;245:752-5.
14. Koji T, Chedid M, Rubin JS, et al. Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J Cell Biol 1994;125:393-401.
15. Adams JC. Heavy metal intensification of DAB-based HRP reaction product. J Histochem Cytochem 1981;29:775.
16. Ehara H, Koji T, Deguchi T, et al. Expression of estrogen receptor in diseased human prostate assessed by non-radioactive in situ hybridization and immunohistochemistry. Prostate 1995;27: 304-13.
17. Takasaka T, Houzawa K, Adachi M, et al. Pathogenesis of attic retractions and attic cholesteatomas. In: Sanna M, ed. Cholesteatoma and Mastoid Surgery the Fifth International Conference. Rome, Italy: Cic Edizioni Int, 1996:296-300.
18. Boismenu R, Havran WL. Modulation of epithelial cell growth by intraepithelial FCT cells. Science 1994;266:1253-5.
19. Finch PW, Cheng AL. Analysis of the cellular basis of keratinocyte growth factor overexpression in inflammatory bowel disease. Gut 1999;45:848-55.
20. Jameson J, Ugarte K, Chen N, et al. A role for skin FCT cells in wound repair. Science 2002;296:747-9.
21. Yellon RF, Leonard G, Marucha PT, et al. Characterization of cytokines present in middle ear effusions. Laryngoscope 1991; 101:165-9.
22. Yeiser S, Satar B, Aydin N. Expression of epithelial growth factor, tumor necrosis factorYalpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma. Otol Neurotol 2002;23: 647-52.
23. Brauchle M, Angermeyer K, Hubner G, et al. Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts. Oncogene 1994;9:3199-204.
24. Chedid M, Rubin JS, Csaky KG, et al. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem 1994; 269:10753-7.
25. Finch PW, Lengel C, Chedid M. Cloning and characterization of the promoter region of the human keratinocyte growth factor gene. J Biol Chem 1995;270:11230-7.